Article
The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection.
RNA biology - 1 Jan 2000
Mansjö Mikael, Johansson Jörgen
Abstract excerpt
During recent years, riboswitches have emerged as potential targets for novel antibacterial substances. In this study, we investigated how one flavin analog, roseoflavin, affected the gene-expression, growth and infectivity of the human bacterial pathogen Listeria monocytogenes to determine the potential of this analog to function as an antibacterial substance. The results indicate that roseoflavin has a profound...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
